Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suppression With Empagliflozin as an Alternative To High-Fat Low-Carbohydrate Diet for Myocardial FDG-PET Imaging

NCT06350903 is registered in ClinicalTrials.gov with Matthieu Pelletier-Galarneau, MD MSc as lead sponsor.

NCT NCT06350903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06350903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suppression With Empagliflozin as an Alternative To High-Fat Low-Carbohydrate Diet for Myocardial FDG-PET Imaging
Lead sponsor
Matthieu Pelletier-Galarneau, MD MSc
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2024
Completion date
November 1, 2024
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial suppression